Cargando…

SLC26A9 deficiency causes gastric intraepithelial neoplasia in mice and aggressive gastric cancer in humans

BACKGROUND: Solute carrier family 26 member (SLC26A9) is a Cl(−) uniporter with very high expression levels in the gastric mucosa. Here, we describe morphological and molecular alterations in gastric mucosa of slc26a9(−/−) mice and in selective parietal cell-deleted slc26a9(fl/fl)/Atp4b-Cre mice and...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xuemei, Li, Taolang, Ma, Zhiyuan, Riederer, Brigitte, Yuan, Dumin, Zhu, Jiaxing, Li, Yunhua, An, Jiaxing, Wen, Guorong, Jin, Hai, Yang, Xiao, Seidler, Ursula, Tuo, Biguang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9187568/
https://www.ncbi.nlm.nih.gov/pubmed/35426084
http://dx.doi.org/10.1007/s13402-022-00672-x
_version_ 1784725200908058624
author Liu, Xuemei
Li, Taolang
Ma, Zhiyuan
Riederer, Brigitte
Yuan, Dumin
Zhu, Jiaxing
Li, Yunhua
An, Jiaxing
Wen, Guorong
Jin, Hai
Yang, Xiao
Seidler, Ursula
Tuo, Biguang
author_facet Liu, Xuemei
Li, Taolang
Ma, Zhiyuan
Riederer, Brigitte
Yuan, Dumin
Zhu, Jiaxing
Li, Yunhua
An, Jiaxing
Wen, Guorong
Jin, Hai
Yang, Xiao
Seidler, Ursula
Tuo, Biguang
author_sort Liu, Xuemei
collection PubMed
description BACKGROUND: Solute carrier family 26 member (SLC26A9) is a Cl(−) uniporter with very high expression levels in the gastric mucosa. Here, we describe morphological and molecular alterations in gastric mucosa of slc26a9(−/−) mice and in selective parietal cell-deleted slc26a9(fl/fl)/Atp4b-Cre mice and correlate SLC26A9 expression levels with morphological and clinical parameters in a cohort of gastric cancer (GC) patients. METHODS: The expression patterns of genes related to transport and enzymatic function, proliferation, apoptosis, inflammation, barrier integrity, metaplasia and neoplasia development were studied by immunohistochemistry (IHC), quantitative RT-PCR, in situ hybridization and RNA microarray analysis. SLC26A9 expression and cellular/clinical phenotypes were studied in primary human GC tissues and GC cell lines. RESULTS: We found that both complete and parietal cell-selective Slc26a9 deletion in mice caused spontaneous development of gastric premalignant and malignant lesions. Dysregulated differentiation of gastric stem cells in an inflammatory environment, activated Wnt signaling, cellular hyperproliferation, apoptosis inhibition and metaplasia were observed. Analysis of human gastric precancerous and cancerous tissues revealed that SLC26A9 expression progressively decreased from atrophic gastritis to GC, and that downregulation of SLC26A9 was correlated with patient survival. Exogenous expression of SLC26A9 in GC cells induced upregulation of the Cl(−)/HCO(3)(−) exchanger AE2, G2/M cell cycle arrest and apoptosis and suppressed their proliferation, migration and invasion. CONCLUSIONS: Our data indicate that SLC26A9 deletion in parietal cells is sufficient to trigger gastric metaplasia and the development of neoplastic lesions. In addition, we found that SLC26A9 expression decreases during human gastric carcinogenesis, and that exogenous SLC26A9 expression in GC cells reduces their malignant behavior. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s13402-022-00672-x.
format Online
Article
Text
id pubmed-9187568
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Netherlands
record_format MEDLINE/PubMed
spelling pubmed-91875682022-06-12 SLC26A9 deficiency causes gastric intraepithelial neoplasia in mice and aggressive gastric cancer in humans Liu, Xuemei Li, Taolang Ma, Zhiyuan Riederer, Brigitte Yuan, Dumin Zhu, Jiaxing Li, Yunhua An, Jiaxing Wen, Guorong Jin, Hai Yang, Xiao Seidler, Ursula Tuo, Biguang Cell Oncol (Dordr) Original Article BACKGROUND: Solute carrier family 26 member (SLC26A9) is a Cl(−) uniporter with very high expression levels in the gastric mucosa. Here, we describe morphological and molecular alterations in gastric mucosa of slc26a9(−/−) mice and in selective parietal cell-deleted slc26a9(fl/fl)/Atp4b-Cre mice and correlate SLC26A9 expression levels with morphological and clinical parameters in a cohort of gastric cancer (GC) patients. METHODS: The expression patterns of genes related to transport and enzymatic function, proliferation, apoptosis, inflammation, barrier integrity, metaplasia and neoplasia development were studied by immunohistochemistry (IHC), quantitative RT-PCR, in situ hybridization and RNA microarray analysis. SLC26A9 expression and cellular/clinical phenotypes were studied in primary human GC tissues and GC cell lines. RESULTS: We found that both complete and parietal cell-selective Slc26a9 deletion in mice caused spontaneous development of gastric premalignant and malignant lesions. Dysregulated differentiation of gastric stem cells in an inflammatory environment, activated Wnt signaling, cellular hyperproliferation, apoptosis inhibition and metaplasia were observed. Analysis of human gastric precancerous and cancerous tissues revealed that SLC26A9 expression progressively decreased from atrophic gastritis to GC, and that downregulation of SLC26A9 was correlated with patient survival. Exogenous expression of SLC26A9 in GC cells induced upregulation of the Cl(−)/HCO(3)(−) exchanger AE2, G2/M cell cycle arrest and apoptosis and suppressed their proliferation, migration and invasion. CONCLUSIONS: Our data indicate that SLC26A9 deletion in parietal cells is sufficient to trigger gastric metaplasia and the development of neoplastic lesions. In addition, we found that SLC26A9 expression decreases during human gastric carcinogenesis, and that exogenous SLC26A9 expression in GC cells reduces their malignant behavior. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s13402-022-00672-x. Springer Netherlands 2022-04-14 2022 /pmc/articles/PMC9187568/ /pubmed/35426084 http://dx.doi.org/10.1007/s13402-022-00672-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Liu, Xuemei
Li, Taolang
Ma, Zhiyuan
Riederer, Brigitte
Yuan, Dumin
Zhu, Jiaxing
Li, Yunhua
An, Jiaxing
Wen, Guorong
Jin, Hai
Yang, Xiao
Seidler, Ursula
Tuo, Biguang
SLC26A9 deficiency causes gastric intraepithelial neoplasia in mice and aggressive gastric cancer in humans
title SLC26A9 deficiency causes gastric intraepithelial neoplasia in mice and aggressive gastric cancer in humans
title_full SLC26A9 deficiency causes gastric intraepithelial neoplasia in mice and aggressive gastric cancer in humans
title_fullStr SLC26A9 deficiency causes gastric intraepithelial neoplasia in mice and aggressive gastric cancer in humans
title_full_unstemmed SLC26A9 deficiency causes gastric intraepithelial neoplasia in mice and aggressive gastric cancer in humans
title_short SLC26A9 deficiency causes gastric intraepithelial neoplasia in mice and aggressive gastric cancer in humans
title_sort slc26a9 deficiency causes gastric intraepithelial neoplasia in mice and aggressive gastric cancer in humans
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9187568/
https://www.ncbi.nlm.nih.gov/pubmed/35426084
http://dx.doi.org/10.1007/s13402-022-00672-x
work_keys_str_mv AT liuxuemei slc26a9deficiencycausesgastricintraepithelialneoplasiainmiceandaggressivegastriccancerinhumans
AT litaolang slc26a9deficiencycausesgastricintraepithelialneoplasiainmiceandaggressivegastriccancerinhumans
AT mazhiyuan slc26a9deficiencycausesgastricintraepithelialneoplasiainmiceandaggressivegastriccancerinhumans
AT riedererbrigitte slc26a9deficiencycausesgastricintraepithelialneoplasiainmiceandaggressivegastriccancerinhumans
AT yuandumin slc26a9deficiencycausesgastricintraepithelialneoplasiainmiceandaggressivegastriccancerinhumans
AT zhujiaxing slc26a9deficiencycausesgastricintraepithelialneoplasiainmiceandaggressivegastriccancerinhumans
AT liyunhua slc26a9deficiencycausesgastricintraepithelialneoplasiainmiceandaggressivegastriccancerinhumans
AT anjiaxing slc26a9deficiencycausesgastricintraepithelialneoplasiainmiceandaggressivegastriccancerinhumans
AT wenguorong slc26a9deficiencycausesgastricintraepithelialneoplasiainmiceandaggressivegastriccancerinhumans
AT jinhai slc26a9deficiencycausesgastricintraepithelialneoplasiainmiceandaggressivegastriccancerinhumans
AT yangxiao slc26a9deficiencycausesgastricintraepithelialneoplasiainmiceandaggressivegastriccancerinhumans
AT seidlerursula slc26a9deficiencycausesgastricintraepithelialneoplasiainmiceandaggressivegastriccancerinhumans
AT tuobiguang slc26a9deficiencycausesgastricintraepithelialneoplasiainmiceandaggressivegastriccancerinhumans